A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment

We present a subgroup analysis of the first double-blind, placebo-controlled, randomised trial with vitamin D3 in MS. In the overall study population, there were 34 patients in the vitamin D arm and 32 patients in the placebo arm. All the patients were using interferon-β-1b (IFNB) therapy. The subgr...

Descripción completa

Detalles Bibliográficos
Autores principales: Åivo, J., Lindsröm, B.-M., Soilu-Hänninen, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420140/
https://www.ncbi.nlm.nih.gov/pubmed/22919492
http://dx.doi.org/10.1155/2012/802796

Ejemplares similares

Ejemplares similares